A circularly permuted CasRx platform for efficient, site-specific RNA editing

IF 33.1 1区 生物学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Yuanming Wang, Kaiwen Ivy Liu, Mengying Mandy Liu, Kean Hean Ooi, Tram Anh Nguyen, Jiunn En Chee, Shun Xiang Danny Teo, Shan He, Jie Wen Douglas Tay, Seok Yee Teo, Kai Shin Liew, Xiao Yu Ge, Zhi Jian Ng, Hasmik Avagyan, Hao Liu, Zirong Yi, Keziah Chang, Eng Piew Louis Kok, Runjia Chen, Chun En Yau, Jun Wei Koh, Yue Wan, Meng How Tan
{"title":"A circularly permuted CasRx platform for efficient, site-specific RNA editing","authors":"Yuanming Wang, Kaiwen Ivy Liu, Mengying Mandy Liu, Kean Hean Ooi, Tram Anh Nguyen, Jiunn En Chee, Shun Xiang Danny Teo, Shan He, Jie Wen Douglas Tay, Seok Yee Teo, Kai Shin Liew, Xiao Yu Ge, Zhi Jian Ng, Hasmik Avagyan, Hao Liu, Zirong Yi, Keziah Chang, Eng Piew Louis Kok, Runjia Chen, Chun En Yau, Jun Wei Koh, Yue Wan, Meng How Tan","doi":"10.1038/s41587-024-02430-w","DOIUrl":null,"url":null,"abstract":"<p>Inactive Cas13 orthologs have been fused to a mutant human ADAR2 deaminase domain at the C terminus to enable programmable adenosine-to-inosine (A-to-I) RNA editing in selected transcripts. Although promising, existing RNA-editing tools generally suffer from a trade-off between efficacy and specificity, and off-target editing remains an unsolved problem. Here we describe the development of an optimized RNA-editing platform by rational protein engineering, CasRx-based Programmable Editing of RNA Technology (xPERT). We demonstrate that the topological rearrangement of a CasRx K940L mutant by circular permutation results in a robust scaffold for the tethering of a deaminase domain. We benchmark our tool against the REPAIR system and show that xPERT exhibits strong on-target activity like REPAIRv1 but low off-target editing like REPAIRv2. Our xPERT platform can be used to alter RNA sequence information without risking genome damage, effect temporary cellular changes and customize protein function.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":null,"pages":null},"PeriodicalIF":33.1000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1038/s41587-024-02430-w","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Inactive Cas13 orthologs have been fused to a mutant human ADAR2 deaminase domain at the C terminus to enable programmable adenosine-to-inosine (A-to-I) RNA editing in selected transcripts. Although promising, existing RNA-editing tools generally suffer from a trade-off between efficacy and specificity, and off-target editing remains an unsolved problem. Here we describe the development of an optimized RNA-editing platform by rational protein engineering, CasRx-based Programmable Editing of RNA Technology (xPERT). We demonstrate that the topological rearrangement of a CasRx K940L mutant by circular permutation results in a robust scaffold for the tethering of a deaminase domain. We benchmark our tool against the REPAIR system and show that xPERT exhibits strong on-target activity like REPAIRv1 but low off-target editing like REPAIRv2. Our xPERT platform can be used to alter RNA sequence information without risking genome damage, effect temporary cellular changes and customize protein function.

Abstract Image

用于高效、特定位点 RNA 编辑的环状包被 CasRx 平台
无活性的Cas13同源物在C端与突变的人类ADAR2脱氨酶结构域融合,从而在选定的转录本中实现可编程的腺苷-肌苷(A-to-I)RNA编辑。尽管前景广阔,但现有的 RNA 编辑工具一般都要在有效性和特异性之间权衡,而且脱靶编辑仍是一个尚未解决的问题。在这里,我们介绍了通过合理蛋白质工程开发的优化 RNA 编辑平台--基于 CasRx 的可编程 RNA 编辑技术(xPERT)。我们证明,通过循环置换对 CasRx K940L 突变体进行拓扑重排,可以为脱氨酶结构域的拴系提供一个稳健的支架。我们将我们的工具与 REPAIR 系统进行了比对,结果表明 xPERT 与 REPAIRv1 一样具有很强的靶上活性,但与 REPAIRv2 一样具有很低的脱靶编辑能力。我们的 xPERT 平台可用于改变 RNA 序列信息,而无需冒基因组受损的风险,并可实现暂时的细胞变化和定制蛋白质功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nature biotechnology
Nature biotechnology 工程技术-生物工程与应用微生物
CiteScore
63.00
自引率
1.70%
发文量
382
审稿时长
3 months
期刊介绍: Nature Biotechnology is a monthly journal that focuses on the science and business of biotechnology. It covers a wide range of topics including technology/methodology advancements in the biological, biomedical, agricultural, and environmental sciences. The journal also explores the commercial, political, ethical, legal, and societal aspects of this research. The journal serves researchers by providing peer-reviewed research papers in the field of biotechnology. It also serves the business community by delivering news about research developments. This approach ensures that both the scientific and business communities are well-informed and able to stay up-to-date on the latest advancements and opportunities in the field. Some key areas of interest in which the journal actively seeks research papers include molecular engineering of nucleic acids and proteins, molecular therapy, large-scale biology, computational biology, regenerative medicine, imaging technology, analytical biotechnology, applied immunology, food and agricultural biotechnology, and environmental biotechnology. In summary, Nature Biotechnology is a comprehensive journal that covers both the scientific and business aspects of biotechnology. It strives to provide researchers with valuable research papers and news while also delivering important scientific advancements to the business community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信